Novaerus has announced the launch of the Defend 1050 – a portable, easy to use device ideal for rapid disinfection and purification of the air in large spaces and high-risk situations such as operating theatres, ICUs, IVF labs, emergency and waiting rooms.

Hospital pathogens infect nearly 6 million patients each year, antibiotic resistance is on the rise, and compliance with hand hygiene and surface cleaning protocols well below standard. Now more than ever, healthcare facilities must deploy innovative technologies that address airborne pathogens and particulate to supplement hand hygiene and surface cleaning to reduce the risk of direct and indirect transmission of infection. 

The Defend 1050 brings long-awaited innovation to the infection control market with ultra-low energy plasma technology – a highly powerful yet extremely gentle method of rapid pathogen destruction – combined with a high-performance multi-stage filter system from Camfil®. 

The all-in-one Defend 1050 can be operated continuously around patients and staff to kill airborne pathogens, adsorb odours, neutralise volatile organic compounds (VOCs), and trap particulate as small as 0.3µm.

Independent tests completed to date show that the Defend 1050 at max speed reduces: 

  • Mycobacterium smegmatis (surrogate for Mycobacterium tuberculosis) by 97 per cent in 30 minutes (30m3 space)
  • Influenza A by 99.9 per cent in 10-20 minutes (28.5mspace)
  • Staphylococcus epidermidis by 99.9 per cent in 15 minutes (30m3 space)
  • Aspergillus niger by 99.99 per cent in 30 minutes (15.9m3 space)
  • Nitrogen Dioxide (NO2) by 100 per cent in six minutes (16m3 space)
  • VOCs at a clean air delivery rate (CADR) of 596 m3/hr
  • PM1.0 at a CADR of 860 m3/hr (19.7m3 space)
  • PM2.5 at a CADR of 870 m3/hr (19.7m3 space)

The Defend 1050 combines six coils of Novaerus’ patented, NASA-tested, ultra-low energy plasma technology with an M5 pre-filter, a genuine H13 HEPA filter certified in accordance with EN-1822, and carbon/molecular filter from Camfil, a world leader in high-quality air filtration.

Since 2009, Novaerus has been researching and developing plasma technology that is unmatched in its ability to safely destroy airborne pathogens that lead to infection in populated indoor spaces. The patented technology uses short-exposure, ultra-low energy plasma that has been tested and shown by several respected laboratories – including Airmid, Aerosol, Microbac, ARE, and Ames – to deactivate pathogens on contact.

Many air cleaning methods in use by healthcare facilities rely on filters to capture pathogens. But without deactivating those pathogens first, the filter can become a safe haven for viable pathogens to colonise. The Novaerus plasma technology solves that problem by killing airborne pathogens before they become trapped in the filter. 

The Defend 1050 can be moved easily by staff and plugged into any power outlet. It has five fan speeds to accommodate different room sizes and noise level requirements. 

Click here to download our free white paper about the limitations of hand hygiene and surface cleaning in the superbug era and how closing the loop by disinfecting the air is the future of infection control.

To learn more about the Defend 1050, visit: www.novaerus1050.com

www.novaerus.com